Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)

NCT03087032 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Patients
Overweight and Obesity
Hyperglycaemia (Diabetic)

Interventions

DRUG: Liraglutide
DRUG: insulin glargine

Sponsor

The First Affiliated Hospital of Xiamen University